Table 2.

Mean density values of newly formed tissues in 6 months after implanting the gene-activated bone substitute.

Patient number	Density of newly formed bone tissue, HU (M ± σ)	Outcome, +/–
1	887.8 ± 172.43	+
2	1, 119.68 ± 201.19	+
3	863.22 ± 111.49	+
4	1, 009.37 ± 174.10	+
5	948.59 ± 121.88	+
6	981.56 ± 150.88	+
7	1, 067.13 ± 210.46	+
8	902.45 ± 105.35	+
9	774.56 ± 118.30	+
10	817.85 ± 135.51	+
11	716.37 ± 140.22	+
12	1, 100.02 ± 147.99	+
13	912.13 ± 181.36	+
14	855.45 ± 162.93	+
15	864.71 ± 115.80	+
16	715.7 ± 99.57	+
17	951.27 ± 128.31	+
18	991.2 ± 144.53	+
19	836.82 ± 129.58	+
20*	846.81 ± 192.71	+
Mean value	908.13 ± 114.40
Total, success rate, %		100

^*Data from the patient who completed the clinical trial at 4.5 months after surgery.